Mainstream

Atai Life Sciences down 12% after hours on mid-stage failure of schizophrenia asset

Atai Life Sciences down 12% after hours on mid-stage failure of schizophrenia asset

Post ContentataiRead More

You might also be interested in reading Nordea Bank GAAP EPS of €0.32, net interest income of €1.85B; initiates FY25 outlook.

July 25, 2025
In Mainstream